Teresa L Kauf

Summary

Affiliation: University of Florida
Country: USA

Publications

  1. pmc Trends in the prevalence of thrombocytopenia among individuals infected with hepatitis C virus in the United States, 1999-2008
    Teresa L Kauf
    Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA
    BMC Res Notes 5:142. 2012
  2. doi request reprint The cost of health care for children and adults with sickle cell disease
    Teresa L Kauf
    Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA
    Am J Hematol 84:323-7. 2009
  3. doi request reprint Cost-utility analysis of rimonabant in the treatment of obesity
    Christian Hampp
    Pharmacy Health Care Administration, College of Pharmacy, University of Florida, Gainesville, FL 32610 0496, USA
    Value Health 11:389-99. 2008
  4. doi request reprint A predictive model of health state utilities for HIV patients in the modern era of highly active antiretroviral therapy
    Teresa L Kauf
    Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL 32610 0496, USA
    Value Health 11:1144-53. 2008
  5. doi request reprint Methodological concerns with economic evaluations of meningococcal vaccines
    Teresa L Kauf
    Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA
    Pharmacoeconomics 28:449-61. 2010
  6. doi request reprint Economic efficiency of genetic screening to inform the use of abacavir sulfate in the treatment of HIV
    Teresa L Kauf
    University of Florida, Gainesville, Florida, USA
    Pharmacoeconomics 28:1025-39. 2010

Detail Information

Publications6

  1. pmc Trends in the prevalence of thrombocytopenia among individuals infected with hepatitis C virus in the United States, 1999-2008
    Teresa L Kauf
    Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA
    BMC Res Notes 5:142. 2012
    ..Bi-yearly data from the 1999-2000 to 2007-2008 National Health and Nutrition Examination Surveys (NHANES) were used to examine the prevalence of thrombocytopenia among HCV-infected individuals in the United States...
  2. doi request reprint The cost of health care for children and adults with sickle cell disease
    Teresa L Kauf
    Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA
    Am J Hematol 84:323-7. 2009
    ..Interventions designed to prevent SCD complications and avoid hospitalizations may reduce the significant economic burden of the disease...
  3. doi request reprint Cost-utility analysis of rimonabant in the treatment of obesity
    Christian Hampp
    Pharmacy Health Care Administration, College of Pharmacy, University of Florida, Gainesville, FL 32610 0496, USA
    Value Health 11:389-99. 2008
    ..To estimate the incremental cost-utility ratio (ICUR) of rimonabant 20 mg/day in the treatment of obesity from a third-party payer's perspective...
  4. doi request reprint A predictive model of health state utilities for HIV patients in the modern era of highly active antiretroviral therapy
    Teresa L Kauf
    Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL 32610 0496, USA
    Value Health 11:1144-53. 2008
    ..The objective of this study was to examine the marginal impact of dosing, adverse events (AEs), and other factors on patients' health state utilities...
  5. doi request reprint Methodological concerns with economic evaluations of meningococcal vaccines
    Teresa L Kauf
    Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA
    Pharmacoeconomics 28:449-61. 2010
    ..Although comparisons across studies are difficult at best, recent work shows that incorporating the indirect benefits and costs of vaccination substantially improves cost effectiveness...
  6. doi request reprint Economic efficiency of genetic screening to inform the use of abacavir sulfate in the treatment of HIV
    Teresa L Kauf
    University of Florida, Gainesville, Florida, USA
    Pharmacoeconomics 28:1025-39. 2010
    ..Genetic screening for HLA-B*5701 can identify patients who are likely to experience an HSR and reduces the incidence of the reaction...